News
Verywell Health on MSN1mon
5 Stages of Chronic Kidney Disease (CKD) From First Symptoms to Kidney FailureWith stage 3b, a person is more likely to experience overt signs of kidney disease and would typically be referred to a ...
Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...
News-Medical.Net on MSN13d
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...
Bagsværd, Denmark Tuesday, April 1, 2025, 18:00 Hrs [IST] ...
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established atherosclerotic disease, CKD, or both.
The trial aims to determine the effects of aldosterone receptor antagonism on mortality and cardiovascular outcomes (onset or progression of cardiovascular disease) in patients with stage 3b CKD ...
Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL trial finds Rybelsus lowers cardiovascular risk by 14%.
BAGSVAERD, Denmark I March 29, 2025 I Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback